The paper is a mini-review (51 references) in Protein Engineering, Design and Selection synthesizing how conformational landscapes govern enzyme evolvability. Its central claims are supported by concrete quantitative cases rather than vague narrative: the His254Arg phosphotriesterase mutation yields an 8-fold turnover change, Asp233Glu alone 2-fold, but the double mutant gives 680-fold β a 42-fold epistatic surplus over the 16-fold multiplicative expectation . The Kemp eliminase HG3 trajectory reports >200-fold activity gain with elimination of a crystallographically observable inactive conformation .
The log-scale figure makes the epistatic surplus visually decisive: observed combined effects (red) dwarf the multiplicative expectation (light blue), and the review attributes this mechanistically to remote mutations constraining Arg254 into its productive 'bent' rotamer β an author interpretation grounded in structural analysis, not a directly observed time-resolved measurement.
Strengths: clear tripartite framework (minor substates β enrichment β epistasis β engineering), honest about the field's predictive limits, and the authors explicitly acknowledge that targeted introduction of novel dynamic pathways remains unsolved . No conflicts of interest are declared; funding is public (ARC, HFSP, ANU).
Blindspots: (1) Selection bias β every flagship example (Ξ±-esterase 7, Ξ²-lactamase, HG3/KE07, phosphotriesterase, CypA, tryptophan synthase) is one where dynamics explanations succeeded; enzymes where dynamics were irrelevant to evolution are not systematically surveyed, so the generality of the framework is unquantified. (2) Heavy reliance on MD-based inference (MSMs, Boltzmann docking, contact networks) whose force-field sensitivity is not discussed. (3) The epistasis numbers are single-trajectory observations without error bars or replicates reported here. (4) Being a 2021 review, it predates confirmatory follow-on work; a later OXA-48 study independently validated the substate-tuning framework, showing ceftazidime kcat/burst rising from 0.008 sβ»ΒΉ (WT) to 0.15 sβ»ΒΉ (F72L/S212A) via conformational-landscape rewiring β with an explicit trade-off (meropenem kcat fell from 0.13 to 0.009 sβ»ΒΉ) β supporting the review's thesis but also revealing promiscuity trade-offs the review underplays.
What would change the conclusion: systematic mutational scans showing that most activity-enhancing distal mutations act through stability/allostery unrelated to substate reshuffling, or MD predictions of landscape shifts failing prospectively at scale. Currently, the framework is best treated as a well-supported interpretive lens with unproven predictive power β exactly how the authors themselves frame it.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.